Prothena (STU:0PT) Total Liabilities: €32.25 Mil (As of Mar. 2026)


STU:0PT Prothena Corp PLC STU:0PT
74 GF Score
Price €8.13
GF Value €12.89
! 3 Warning Signs
View Full Analysis

What is Prothena Total Liabilities?

Prothena STU:0PT -3.44% 74 Total Liabilities is €32.25 Mil as of Mar. 2026. GuruFocus rates STU:0PT with a GF Score™ of 74/100 and a GF Value™ of €12.89. The stock has 3 warning signs investors should review.

Prothena's Total Liabilities for the quarter that ended in Mar. 2026 was €32.25 Mil.

Prothena's quarterly Total Liabilities declined from Sep. 2025 (€49.11 Mil) to Dec. 2025 (€39.57 Mil) and declined from Dec. 2025 (€39.57 Mil) to Mar. 2026 (€32.25 Mil).

Prothena's annual Total Liabilities declined from Dec. 2023 (€123.81 Mil) to Dec. 2024 (€57.47 Mil) and declined from Dec. 2024 (€57.47 Mil) to Dec. 2025 (€39.57 Mil).

Prothena Total Liabilities Historical Data

* Premium members only.

The historical data trend for Prothena's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Prothena Total Liabilities Chart

Prothena Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 126.84 128.38 123.81 57.47 39.57

Prothena Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 53.33 64.80 49.11 39.57 32.25
STU:0PT
74GF Score
Prothena Corp PLC STU:0PT
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Prothena Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Prothena's Total Liabilities for the fiscal year that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=34.88+(4.686+0
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=39.57

Total Liabilities=Total Assets (A: Dec. 2025 )-Total Equity (A: Dec. 2025 )
=279.091-239.525
=39.57

Prothena's Total Liabilities for the quarter that ended in Mar. 2026 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=28.127+(4.118+-1.7763568394003E-15
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=32.25

Total Liabilities=Total Assets (Q: Mar. 2026 )-Total Equity (Q: Mar. 2026 )
=302.658-270.413
=32.25

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of €32.25 Mil mean?
Prothena (STU:0PT) has a Total Liabilities of €32.25 Mil as of Mar. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Prothena and its competitors.
Is Prothena's Total Liabilities too high?
Prothena's current Total Liabilities is €32.25 Mil. Overall, Prothena has a GF Score™ of 74/100, reflecting its overall financial health beyond just this single metric.
How does Prothena's Total Liabilities compare to CTNM and ASMB?
Prothena's Total Liabilities of €32.25 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Biotechnology company?
A good Total Liabilities depends on the Biotechnology industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Prothena and its competitors. Prothena's current Total Liabilities is €32.25 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Prothena stock overvalued right now?
Prothena (STU:0PT) has a current Total Liabilities of €32.25 Mil. The stock's GF Value™ is €12.89, compared to a current price of €8.13 — trading 36.9% below its estimated fair value. The current Total Liabilities is €32.25 Mil. Prothena's overall GF Score™ is 74/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Prothena (STU:0PT), the current Total Liabilities is €32.25 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Prothena (STU:0PT) Overvalued in 2026?

Based on GuruFocus' analysis, Prothena stock appears to be undervalued. The current stock price of €8.13 is trading 36.9% below its estimated GF Value™ of €12.89.

Key valuation signals for STU:0PT:

  • Total Liabilities: €32.25 Mil
  • GF Value™: €12.89 vs. price of €8.13 (36.9% below fair value)
  • GF Score™: 74/100 with 3 warning signs

No single metric tells the full story. See the STU:0PT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Prothena Business Description

Other Exchanges PRTA:USA0Y3M:UK0PT:Germany
Address 77 Sir John Rogerson’s Quay, Block C, Grand Canal Docklands, Dublin 2, Dublin, IRL, D02 VK60
Prothena Corp PLC is a late-stage clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases. Prothena is developing and applying its proprietary CYTOPE technology to target a broad spectrum of intracellular disease pathways in the brain and periphery. The company's pipeline includes both wholly-owned and partnered programs like Prasinezumab, Coramitug (PRX004), BMS-986446 (PRX005), PRX019, TDP-43 CYTOPE, and PRX012-TfR, being developed for the potential treatment of Parkinson's disease, ATTR amyloidosis with cardiomyopathy, Alzheimer's disease, Amyotrophic lateral sclerosis (ALS), and other neurodegenerative diseases.
74GF Score

Get the complete analysis for STU:0PT

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€8.13
Price
€12.89
GF Value